Tg Therapeutics (TGTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -55,781 | -20,478 | -26,183 | -889 | 624 |
| Depreciation Amortization | 198 | 2 | 0 | N/A | 356 |
| Accounts receivable | N/A | N/A | N/A | N/A | -245 |
| Other Working Capital | -6,047 | 4,151 | 706 | 419 | 196 |
| Other Operating Activity | 26,571 | 5,586 | 20,289 | 384 | -2,901 |
| Operating Cash Flow | $-35,060 | $-10,739 | $-5,188 | $-87 | $-1,970 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -18,337 | -4,920 | N/A | N/A | N/A |
| PPE Investments | -19 | -6 | -1 | N/A | -3 |
| Net Acquisitions | N/A | N/A | N/A | 10 | 519 |
| Investing Cash Flow | $-18,355 | $-4,926 | $-1 | $10 | $517 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 40 |
| Debt Repayment | -678 | N/A | N/A | N/A | -289 |
| Common Stock Issued | 69,373 | 39,929 | 0 | 9,825 | 2,164 |
| Common Stock Repurchased | N/A | -150 | -85 | N/A | N/A |
| Other Financing Activity | -52 | -85 | 11,981 | 0 | 0 |
| Financing Cash Flow | $68,644 | $39,694 | $11,897 | $9,825 | $1,914 |
| Beginning Cash Position | 40,486 | 16,456 | 9,749 | N/A | 18 |
| End Cash Position | 55,714 | 40,486 | 16,456 | 9,749 | 479 |
| Net Cash Flow | $15,228 | $24,030 | $6,708 | $9,749 | $461 |
| Free Cash Flow | |||||
| Operating Cash Flow | -35,060 | -10,739 | -5,188 | -87 | -1,970 |
| Capital Expenditure | -19 | -6 | -1 | N/A | -3 |
| Free Cash Flow | -35,079 | -10,745 | -5,189 | -87 | -1,973 |